Search

Your search keyword '"Chen, H-C"' showing total 2,464 results

Search Constraints

Start Over You searched for: Author "Chen, H-C" Remove constraint Author: "Chen, H-C"
2,464 results on '"Chen, H-C"'

Search Results

4. The Gaia-ESO Survey: Extracting diffuse interstellar bands from cool star spectra, DIB-based interstellar medium line-of-sight structures at the kpc scale

8. The crystal growth and characterization of NaxCoO2 and NaxCoO2yH2O

9. Quantum Holonomy in Three-dimensional General Covariant Field Theory and Link Invariant

14. A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

15. RpoS contributes in a host-dependent manner to Salmonella colonization of the leaf apoplast during plant disease

19. 1368P TALAPRO-1: Talazoparib monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) – Exploration of tumor genetics associated with prolonged benefit

24. ESICM LIVES 2016: part two: Milan, Italy. 1–5 October 2016

26. Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (vol 12, 278, 2022)

27. P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO-T TRIAL PET/CT SUBSTUDY

35. TALAPRO-3: A phase 3, double-blind, randomized study of enzalutamide (ENZA) plus talazoparib (TALA) vs placebo plus ENZA in patients (pts) with DDR gene mutated metastatic castration-sensitive prostate cancer (mCSPC)

37. Xpros: a Fuzzy Expert System for Prospect Appraisal XPROS : un système expert flou pour l'évaluation de prospects

39. Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer related lymphedema rehabilitation: A proof-of-principle study

43. 645TiP TALAPRO-3: A phase III, double-blind, randomized study of enzalutamide (ENZA) plus talazoparib (TALA) vs placebo plus ENZA in patients (pts) with DDR gene mutated metastatic castration-sensitive prostate cancer (mCSPC)

45. 580P TALAPRO-1: Talazoparib (TALA) monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) - Exploration of non-DDR mutational landscape and potential associations with antitumor activity

50. Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

Catalog

Books, media, physical & digital resources